Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Defniniens, Partek, Geisinger Health System


Tibotec to Use Inpharmatica's Chematica Platform

Inpharmatica said last week that Tibotec Pharmaceuticals, a subsidiary of Johnson & Johnson, will use components of its Chematica software platform for its research in HIV research.

Tibotec will use Inpharmatica's StarLite and DrugStore databases to identify molecular targets, screening assays and alternative indications for bioactive compounds, Inpharmatica said.

Defniniens to Open US Subsidiary

Image informatics firm Definiens of Munich, Germany, said last week that it has formed a wholly owned US subsidiary, Definiens Inc., that will have offices in Boston and Boulder, Colo.

The company "is experiencing significant growth in the US" for its software, said Thomas Heydler, Definiens' CEO, in a statement.

The company said that it is adding staff to its US and European offices "in order to support the growing demand for the new products and solutions."

Ryoka to Distribute Partek Software in Japan

Partek said last week that it has signed an agreement with Ryoka Systems under which Ryoka will act as a "premier" distributor for Partek's software in Japan.

Ryoka will provide sales, marketing, and customer support for four of Partek's statistics and data-visualization software products: Partek Discovery Suite, Partek Genomics Solution, Partek QSAR, and Partek Screener's Solution.

Geisinger Joins Penn Cancer Alliance Bioinformatics Consortium

Geisinger Health System said last week that it has joined the Pennsylvania Cancer Alliance Bioinformatics Consortium.

Geisinger patients will now be able to donate leftover tissues for biopsies to the Geisinger Biospecimen Bank. Geisinger researchers will analyze the tissue, and the results will be added to a state-wide data bank open to any consortium researcher.

Other participants in the consortium include the University of Pittsburgh Cancer Institute, Thomas Jefferson University's Kimmel Cancer Center, Fox Chase Cancer Center, University of Pennsylvania's Abramson Cancer Center, the Wistar Institute, Drexel University, Penn State Cancer Institute, and the Windber Research Institute.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.